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Summary
Rationale This initiative is focused on building a global consensus around core diagnostic criteria for malnutrition in adults in
clinical settings.
Methods In January 2016, the Global Leadership Initiative on Malnutrition (GLIM) was convened by several of the major
global clinical nutrition societies. GLIM appointed a core leadership committee and a supporting working group with represen-
tatives bringing additional global diversity and expertise. Empirical consensus was reached through a series of face-to-face
meetings, telephone conferences, and e-mail communications.
Results A two-step approach for the malnutrition diagnosis was selected, i.e., first screening to identify “at risk” status by the
use of any validated screening tool, and second, assessment for diagnosis and grading the severity of malnutrition. The malnu-
trition criteria for consideration were retrieved from existing approaches for screening and assessment. Potential criteria were
subjected to a ballot among the GLIM core and supporting working group members. The top five ranked criteria included three
phenotypic criteria (weight loss, low body mass index, and reduced muscle mass) and two etiologic criteria (reduced food intake
or assimilation, and inflammation or disease burden). To diagnose malnutrition at least one phenotypic criterion and one
etiologic criterion should be present. Phenotypic metrics for grading severity as Stage 1 (moderate) and Stage 2 (severe)
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malnutrition are proposed. It is recommended that the etiologic criteria be used to guide intervention and anticipated out-
comes. The recommended approach supports classification of malnutrition into four etiology-related diagnosis categories.
Conclusion A consensus scheme for diagnosing malnutrition in adults in clinical settings on a global scale is proposed. Next
steps are to secure further collaboration and endorsements from leading nutrition professional societies, to identify overlaps
with syndromes like cachexia and sarcopenia, and to promote dissemination, validation studies, and feedback. The diagnostic
construct should be re-considered every 3–5 years.
Keywords Malnutrition; Screening; Assessment; Diagnosis
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Introduction
Malnutrition due to disease, poverty, hunger, war, and natu-
ral catastrophe is a fate suffered by greater than 1 billion of
the world’s population. Historically, starvation and famine
were prevalent causes of malnutrition and they remain so to-
day. However, with improvements in agriculture, education,
public health, healthcare, and living standards, nutrition dis-
orders and related conditions now encompass the full scope
of undernutrition, micronutrient abnormalities, obesity, ca-
chexia, sarcopenia, and frailty.1,2
Malnutrition, e.g. undernutrition, may be caused by com-
promised intake or assimilation of nutrients but there is
growing appreciation that malnutrition may also be caused
by disease-associated inflammatory or other mechanisms.
The malnutrition that is associated with disease or injury in-
variably consists of a combination of reduced food intake or
assimilation and varying degrees of acute or chronic inflam-
mation, leading to altered body composition and diminished
biological function.1–3 Inflammation contributes to malnutri-
tion through associated anorexia and decreased food intake
as well as altered metabolism with elevation of resting energy
expenditure and increased muscle catabolism. Altered body
composition manifests as a decrease in any marker of muscle
mass (fat-free mass, muscle mass index or body cell mass).
Thus, malnutrition is associated with adverse functional and
clinical outcomes.
Although malnutrition is a global concern associated with
incremental morbidity, mortality, and cost, there has been
a fundamental lack of consensus on diagnostic criteria for
application in clinical settings. No single existing approach
has secured broad global acceptance.1,4–8 Our evolving un-
derstanding of the contributions of disease/inflammation
may render some concepts of malnutrition in the current
International Classifications of Diseases (ICD-10) (http://
www.who.int/classifications/icd/en/) inconsistent with ap-
proaches or nomenclature that are currently used in clinical
practice and research. Thus, there is an urgent need to
establish a global consensus to be used in clinical care set-
tings for adults.
In order to respond to the needs of the clinical nutrition
and medical communities the Global Leadership Initiative
on Malnutrition (GLIM) was convened in January 2016.
GLIM has engaged several of the clinical nutrition societies
with global reach to focus on standardizing the clinical
practice of malnutrition diagnosis. We also sought to clarify
overlaps with related disease classifications including ca-
chexia. The purpose of this specific initiative is to reach
global consensus on the identification and endorsement
of criteria for the diagnosis of malnutrition in clinical
settings.
Methods
The consensus procedure
On January 19, 2016 the Global Leadership Conversation: Ad-
dressing Malnutrition was held at the ASPEN Conference.9
Key breakthroughs at that meeting led to the development
of GLIM:
1 It was recognized that there was considerable consensus
among stakeholders around many malnutrition diagnosis
issues
2 There was strong commitment for reaching broader global
consensus in defining and characterizing malnutrition
3 A core leadership committee with representatives of
several of the global clinical nutrition societies; ASPEN
(www.nutritioncare.org), ESPEN (www.espen.org),
FELANPE (www.felanpeweb.org) and PENSA (www.pensa-
online.org) was constituted to form GLIM. The core GLIM
leadership committee then created a larger supporting
working group comprised of invited members that brought
additional global diversity and expertise to the consensus
effort.
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4 It was agreed that a series of face-to-face meetings, tele-
phone conferences, and email communications would be
used to delineate the GLIM approach.
The first full meeting of the GLIM extended working group
was held September 19, 2016 at the ESPEN Congress.10
Highlighted objectives included consensus development of
evidence-based criteria suitable to diverse clinical settings,
global dissemination of consensus criteria, and the priority
to seek adoption by leading diagnosis classification and cod-
ing entities across the globe. It was also agreed that the de-
sired approach to malnutrition diagnosis should be simple
and include clinically relevant diagnostic criteria that will be
appropriate for application by all healthcare professionals
using methods that are widely available. The intent was also
to promote global use of consensus criteria that can be read-
ily used with other approaches and additional criteria of re-
gional preference.
Results
Consensus was gradually achieved over the course of the
GLIM meetings held February 20, 2017 at the ASPEN Confer-
ence,11 September 11, 2017 at the ESPEN Congress, and Jan-
uary 25, 2018 at the ASPEN Conference. Meanwhile,
discussions were also held with the leadership of The Society
of Sarcopenia, Cachexia and Wasting Disorders (SCWD).
A two-step model for risk screening and diagnosis
assessment
There was strong consensus that the key first step in the eval-
uation of nutritional status is malnutrition risk screening to
identify “at risk” status by the use of any validated screening
tool12–14; some of these tools are noted in Table 1 and the
Appendix. This is followed by the second step of assessment
for diagnosis and severity grading as described below.
Criteria selected for malnutrition diagnosis
A comprehensive survey of existing approaches used in
screening and assessment of malnutrition was conducted to
identify criteria worthy of consideration (Table 1 and the Ap-
pendix). It was recognized that these approaches incorporate
multiple common criteria. For example, the presence of
weight loss and disease burden or inflammation is common
to most of them as is reduced food intake (Table 1). Potential
consensus criteria from existing approaches as well as addi-
tional criteria suggested by participants were subject to fur-
ther consideration.
In order to establish consensus and endorsement of a min-
imum set of diagnostic criteria by the core leadership com-
mittee and the supporting working group a formal ballot
was administered whereby participants ranked proposed di-
agnosis criteria. The top 5 ranked criteria by an overwhelming
majority of GLIM participants were as follows:
Table 1. Survey of existing approaches used in screening and assessment of malnutrition and cachexia.
NRS-
200212a
MNA-
SF21a,b MUST22a
ESPEN
20158a
ASPEN/
AND7a SGA4a
Evans
20085c
PEW
200823d
Fearon
20116c
Etiologies
Reduced food intake X X X X X X X X
Disease burden/
inflammation
X X X X X X X X X
Symptoms
Anorexia X X X X
Weakness X X X
Signs/Phenotype
Weight loss X X X X X X X X X
Body mass index X X X X X X X
Lean/fat free/
muscle mass
X X X X X X X
Fat mass X X X
Fluid retention/ascites X X
Muscle function; e.g.
grip strength
X X X
Biochemistry X X
NRS-2002: Nutritional Risk Screening-2002, MNA-SF =Mini Nutritional Assessment-Short Form, MUST =Malnutrition Universal Screening
Tool, ESPEN = European Society for Clinical Nutrition and Metabolism, ASPEN = American Society of Parenteral and Enteral Nutrition,
AND = Academy of Nutritiona and Dietetics, SGA = Subjective Global Assessment, PEW=Protein Energy Wasting
aMalnutrition approach
bAdapted for older adults
cCachexia approach
dAdapted for chronic kidney disease
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• Weight loss
• Low body mass index (BMI)
• Reduced muscle mass
• Reduced food intake or assimilation
• Disease burden/inflammation
Weight loss
There was strong GLIM consensus for the inclusion of weight
loss as a phenotypic criterion. Validity is well established and
there is a robust literature on which threshold selection could
be based (Appendix). There must be priority to obtain re-
peated weight measures over time to identify trajectories of
decline, maintenance, and improvement. GLIM participants
felt that it is especially important to recognize the pace of
weight loss early in the course of disease or injury and to
highlight that many patients will have lost appreciable weight
prior to presenting to the healthcare.
Low BMI
There is substantial regional variation in the use of low BMI as a
phenotypic criterion formalnutrition diagnosis. North American
GLIM representatives indicated that low BMI is seldom used as
a clinical malnutrition marker in those regions. The experience
from the current American population is that people are often
overweight or obese and would need to lose substantial weight
before low BMI designation would occur. Since other regions of
the world currently make use of BMI as a criterion for recogni-
tion ofmalnutrition, the GLIM consensus includes low BMI. Fur-
ther research is however needed to secure consensus reference
BMI data for Asian populations in clinical settings.
Reduced muscle mass
Reduced muscle mass is a phenotypic criterion with strong
evidence to support its inclusion in the GLIM consensus
criteria. However, there is not consensus regarding how best
to measure and define reduced muscle mass, particularly in
clinical settings. Therefore, GLIM recommends measurement
by dual-energy absorptiometry or other validated body com-
position measures such as bioelectrical impedance, ultra-
sound, computed tomography or magnetic resonance
imaging, but these methods are still not available in most set-
tings for nutritional assessment throughout the globe. Physi-
cal examination or anthropometric measures of calf or arm
muscle circumference are therefore included as alternative
measures. Recommendations are likely to evolve as portable
and less costly body composition technologies are developed
and become widely available.
For the purpose of recommended cut-off values for muscle
mass reductions, GLIM refers to recommendations from the
European Working Group on Sarcopenia in Older People
(EWGSOP)15 and from The Foundation of National Institute
of Health (FNIH) initiative,16 and the Asian Working Group
on Sarcopenia (AWGS).17 Reference standards for muscle
mass may warrant adjustment for race and sex. Additional re-
search is warranted to establish general reference standards
as well as for some specific populations, e.g. in Asia. Examples
of recommended thresholds are found in Table 2.
Assessment of muscle function using grip strength or other
validated procedures is recommended as a supportive mea-
sure in the GLIM consensus (Tables 3 and 4). Decline in mus-
cle strength generally exceeds changes in muscle size.18
However, irrespective of etiology, appreciable loss of muscle
mass is generally accompanied by reduced muscle function.
In situations where muscle mass cannot be readily assessed
then muscle strength, e.g. hand grip strength, is an appropri-
ate supporting proxy.
Reduced food intake or assimilation
Reduced food intake is a well-established etiologic criterion
for malnutrition that has strong validity. It can have multiple
causes including poor oral health, medication side effects, de-
pression, dysphagia, gastrointestinal complaints, anorexia
and inadequate nutrition support. Thresholds for relevant im-
pairment of food intake are widely reported (Appendix) and
GLIM participants sought to empirically provide a practical
synthesis. Reduced assimilation of food/nutrients is associ-
ated with malabsorptive disorders like short bowel syndrome,
pancreatic insufficiency and after bariatric surgery. It is also
associated with disorders like esophageal strictures,
gastroparesis, and intestinal pseudo-obstruction, as well as
with gastrointestinal symptoms like dysphagia, nausea,
vomiting, diarrhea, constipation, and abdominal pain. These
symptoms have been incorporated as supportive indicators
Table 2. Examples of recommended thresholds for reduced muscle mass
Males Females
Appendicular Skeletal Muscle Index
(ASMI, kg/m2)15
<7.26 <5.25
ASMI, kg/m2241 <7 <6
ASMI, kg/m2172
- DXA <7 <5.4
- BIA <7 <5.7
Fat free mass index (FFMI, kg/m2)8 <17 <15
Appendicular lean mass (ALM, kg)25 <21.4 <14.1
Appendicular lean mass adjusted
for BMI = ALM/BMI26
<0.725 <0.591
DXA = dual energy x-ray absorptiometry, BIA = bioelectrical im-
pedance analysis
BMI = body mass index
1Recommendations from European Working Group on Sarcopenia
in Older People 2 (EWGSOP2); personal communication Alfonso
Cruz-Jentoft.
2Recommendations from Asian Working Group for Sarcopenia
(AWGS) for Asians.
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into this GLIM consensus criterion to help to identify poor
food intake or assimilation.
Disease burden/inflammation
GLIM members recognized that disease burden/inflammation
has become a widely accepted etiologic criterion in existing
screening and assessment tools (Table 1). Clinical diagnosis
provides a simple approach to recognition of severe, chronic
or frequently recurrent inflammation.1,2,19 For example, ma-
jor infections, burns, trauma, and closed head injury are
associated with acute inflammation of a severe degree. Indi-
cators of inflammation may include fever, negative nitrogen
balance, and elevated resting energy expenditure. Most
chronic organ diseases, like congestive heart failure, chronic
obstructive pulmonary disease, rheumatoid arthritis, chronic
kidney or liver disease and cancer, are associated with
chronic or recurrent inflammation of a mild to moderate de-
gree. While severe inflammation is generally easy to discern,
clinical judgement is often required to recognize that of lesser
degree. Supportive proxy measures of inflammation can in-
clude laboratory indicators like serum C-reactive protein
(CRP), albumin, or pre-albumin.
Table 3. Phenotypic and etiologic criteria for the diagnosis of malnutrition.
Phenotypic Criteria* Etiologic Criteria*
Weight loss (%)
Low body mass
index (kg/m2)
Reduced
muscle massa
Reduced food intake
or assimilationb, c Inflammationd,e,f
>5% within past
6 months, or>10%
beyond 6 months
<20 if <70 years, or
<22 if >70 years
Reduced by validated body
composition measuring
techniquesa
≤50% of ER >1 week, or any
reduction for >2 weeks, or
any chronic GI condition that
adversely impacts food
assimilation or absorptionb,c
Acute disease/injuryd,f
or chronic disease-relatede,f
Asia:
<18.5 if <70 years, or
<20 if >70 years
*Requires at least 1 phenotypic criterion and 1 etiologic criterion for diagnosis of malnutrition.
aFor example fat free mass index (FFMI, kg/m2)) by dual-energy absorptiometry (DXA) or corresponding standards using other body com-
position methods like bioelectrical impedance analysis (BIA), CT or MRI. When not available or by regional preference, physical examina-
tion or standard anthropometric measures like mid-arm muscle or calf circumferences may be used. Thresholds for reduced muscle mass
need to be adapted to race (Asia). Functional assessments like hand-grip strength may be considered as a supportive measure.
bConsider gastrointestinal symptoms as supportive indicators that can impair food intake or absorption e.g. dysphagia, nausea, vomiting,
diarrhea, constipation or abdominal pain. Use clinical judgement to discern severity based upon the degree to which intake or absorption
are impaired. Symptom intensity, frequency, and duration should be noted.
cReduced assimilation of food/nutrients is associated with malabsorptive disorders like short bowel syndrome, pancreatic insufficiency
and after bariatric surgery. It is also associated with disorders like esophageal strictures, gastroparesis, and intestinal pseudo-obstruction.
Malabsorption is a clinical diagnosis manifest as chronic diarrhea or steatorrhea. Malabsorption in those with ostomies is evidenced by
elevated volumes of output. Use clinical judgement or additional evaluation to discern severity based upon frequency, duration, and
quantitation of fecal fat and/or volume of losses.
dAcute disease/injury-related. Severe inflammation is likely to be associated with major infection, burns, trauma or closed head injury.
Other acute disease/injury-related conditions are likely to be associated with mild to moderate inflammation.
eChronic disease-related. Severe inflammation is not generally associated with chronic disease conditions. Chronic or recurrent mild to
moderate inflammation is likely to be associated with malignant disease, chronic obstructive pulmonary disease, congestive heart failure,
chronic renal disease or any disease with chronic or recurrent Inflammation. Note that transient inflammation of a mild degree does not
meet the threshold for this etiologic criterion.
fC-reactive protein may be used as a supportive laboratory measure.
GI = gastro-intestinal, ER = energy requirements
Table 4. Thresholds for severity grading of malnutrition into stage 1 (moderate) and stage 2 (severe) malnutrition
Phenotypic Criteriaa
Weight loss (%)
Low body mass
index (kg/m2)b
Reduced
muscle massc
Stage 1/Moderate Malnutrition
(Requires 1 phenotypic criterion
that meets this grade)
5–10% within the past 6 mo, or
10–20% beyond 6 mo
<20 if <70 yr,
<22 if ≥70 yr
Mild to moderate deficit
(per validated assessment
methods – see below)
Stage 2/Severe Malnutrition
(Requires 1 phenotypic criterion
that meets this grade)
>10% within the past 6 mo, or
>20% beyond 6 mo
<18.5 if <70 yr,
<20 if ≥70 yr
Severe deficit (per
validated assessment
methods – see below)
aSeverity grading is based upon the noted phenotypic criteria while the etiologic criteria described in the text and Figure 1 are used to
provide the context to guide intervention and anticipated outcomes.
bFurther research is needed to secure consensus reference BMI data for Asian populations in clinical settings.
cFor example appendicular lean mass index (ALMI, kg/m2) by dual-energy absorptiometry or corresponding standards using other body
composition methods like bioelectrical impedance analysis (BIA), CT or MRI. When not available or by regional preference, physical exam-
ination or standard anthropometric measures like mid-arm muscle or calf circumferences may be used. Functional assessments like hand-
grip strength may be used as a supportive measure.15
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Approach to using combined phenotypic and
etiologic criteria for malnutrition diagnosis
Weight loss, reduced BMI, and reduced muscle mass were
categorized as phenotypic criteria, and reduced food
intake/assimilation and disease burden/inflammation as etio-
logic criteria (Table 3 and Figure 1). For the diagnosis of mal-
nutrition, GLIM recommends that the combination of at least
one phenotypic criterion and one etiologic criterion is re-
quired (Table 3 and Figure 1). The selection of threshold
values for the consensus diagnostic criteria was guided by re-
view of existing approaches used in screening and assess-
ment as was the selection of threshold values for severity
grading described below (see Appendix). The selected thresh-
old values for diagnosis of malnutrition are shown in Table 3.
While only the phenotypic criteria are proposed for the sever-
ity grading that follows, the inclusion of the etiologic criteria
for malnutrition diagnosis is deemed a priority to guide ap-
propriate intervention and anticipated outcomes.
Severity grading of malnutrition
It is clinically useful to categorize the severity of malnutrition
depending on the degree of aberration from established
thresholds. Suggested phenotypic metrics for grading severity
as Stage 1 (moderate) and Stage 2 (severe) malnutrition are
shown in Table 4.
Etiology-based diagnosis classification
An etiology-based diagnosis classification is endorsed by
GLIM consistent with those suggested previously by the Inter-
national Consensus Guideline Committee,1 the AND/ASPEN
Guidelines,7 and the ESPEN Guidelines.2 The classification in-
cludes malnutrition related to chronic disease with inflamma-
tion, malnutrition related to chronic disease with minimal or
no perceived inflammation, malnutrition related to acute dis-
ease or injury with severe inflammation, and malnutrition re-
lated to starvation including hunger/food shortage associated
with socioeconomic or environmental factors (Table 5).
Discussion
This GLIM initiative targets the priority to adopt global con-
sensus criteria so that malnutrition prevalence, interven-
tions, and outcomes may be compared throughout the
Figure 1 GLIM diagnostic scheme for screening, assessment, diagnosis and grading of malnutrition.
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world. A common malnutrition “language” is a paramount
necessity in order to support the development of global
standards of care that will promote improved outcomes.
The proposed approach for diagnosing malnutrition is based
upon a strong consensus endorsing core phenotypic and
etiologic criteria that are already in widespread use
throughout the world. The intent is to promote global use
of these criteria that may in turn be readily used with other
approaches and additional criteria of regional preference.
The consensus criteria are intended to be simple and read-
ily applied by clinicians and other health practitioners using
tools and methods that are readily available. Only modest
training should be required. The proposed approach encom-
passes risk screening and diagnosis but does not entail the
robust detail of comprehensive nutrition assessment. It will
provide a malnutrition diagnosis that may then be
complemented by more comprehensive assessments to pro-
vide the basis for individualized care and treatment plans.
Consultation of skilled nutrition practitioners like dietitians
is recommended for comprehensive assessment based upon
regional preferences and availability. Repeated criterion
measures over time are recommended so that trajectories
of decline, maintenance, and improvement may be
identified.
The recommended GLIM approach encompasses both phe-
notypic and etiologic criteria for the diagnosis of malnutrition
but uses only phenotypic criteria cut-points to provide for se-
verity grading. While etiology has not generally been included
in criteria supporting the diagnosis of medical conditions in
the ICD construct, the inclusion of etiology has been widely
adopted in the clinical nutrition community because it serves
to guide appropriate interventions and expected outcomes.1
For example, the presence of disease-associated inflamma-
tory response has potential for major impacts upon treat-
ment approach and anticipated outcome. The GLIM
approach acknowledges the diversity and the multi-factorial
etiologies underlying the development of the malnourished
phenotype irrespective of body morphology – lean, normal
or obese.
Impairment of muscle strength and function are core phe-
nomena in conditions like sarcopenia,15,16 cachexia,5,6 and
frailty.20 Assessment of muscle strength should be an integral
measure in assessment of patients with suspected sarcopenia
since impairment of muscle strength is now recognized as a
key component for diagnosis of sarcopenia.15,16 Though in-
flammatory mediators and other mechanisms besides malnu-
trition are at play, it is recommended that the GLIM
consensus criteria be applied to diagnose malnutrition in per-
sons with sarcopenia, cachexia, and frailty so that the priority
to undertake appropriate nutrition interventions may be rec-
ognized. The most helpful approaches for these conditions
will however require combined multimodal interventions be-
yond nutritional supplements, like pharmacological agents
and exercise.
Similarly, patients with cachexia will meet GLIM consensus
criteria for malnutrition related to chronic disease with in-
flammation. Since there is concern that inclusion of cachexia
with other disease-related malnutrition conditions may di-
minish appreciation for some distinctive features of cachexia,
there has been understandable hesitation by some to equate
cachexia with this GLIM diagnosis category. The GLIM con-
sensus criteria for malnutrition are therefore intended to be
used in parallel with established concepts and nomenclature,
including for example, those of cachexia, sarcopenia and
frailty.
Conclusion
A strong GLIM consensus endorsed the selected core pheno-
typic and etiologic criteria that are already in widespread use
throughout the world. Many studies provide clear evidence
that the agreed upon criteria for diagnosis of malnutrition
are highly relevant and each of them alone is able to predict
adverse clinical outcomes. Since these criteria may be readily
used with other approaches and additional criteria of regional
preference, their global adoption is more likely. As the initia-
tive moves forward the creation of databases that use the se-
lected criteria will facilitate the comparison of malnutrition
prevalence, interventions, and outcomes throughout the
world. Such observations can be used to support the develop-
ment of global standards of care that will promote improved
outcomes.
After the launch of the GLIM consensus it is important that
the nutrition community use the criteria both in prospective
and retrospective cohort studies as well as clinical trials in or-
der to validate its relevance for clinical practice. Next steps
are to secure endorsements from leading nutrition profes-
sional societies and to promote dissemination, validation
testing, and feedback. The GLIM consensus should be re-
evaluated based upon review of new studies and advances
in screening and assessment every 3–5 years. We will also
seek to share the GLIM consensus recommendations with
the World Health Organization in the context of the Interna-
tional Classification of Diseases revision process (ICD-11). This
is a high priority since this classification scheme guides clinical
diagnosis and reimbursement across much of the world. The
Table 5. Diagnosis category according to underlying etiology
Malnutrition related to
• Chronic disease with inflammation
• Chronic disease with minimal or no perceived inflammation
• Acute disease or injury with severe inflammation
• Starvation including hunger/food shortage associated with socio-
economic or environmental factors
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proposed GLIM consensus criteria target adults in clinical set-
tings but it will also be a priority to work with the World
Health Organization and the United Nations to explore the
potential for use in other global settings like famine.
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Appendix
Table A1. Cut-offs suggested in the major screening tools.
Phenotypic Criteria Etiologic Criteria
Weight loss
Low body mass
index (kg/m2)
Reduced muscle
mass/muscle function
Reduced
food intake
Severe disease/
inflammation
NRS-200212
Mild >5% in 3 mo NS NA 50–75% of required
preceding week
E.g. hip fracture,
chronic disease
Moderate >5% in 2 mo 18.5–20.5 NA 25–60% of required
preceding week
E.g. major abdominal
surgery, stroke
Severe >5% in 1 mo <18.5 NA 0–25% of required
preceding week
E.g. head injury, bone marrow
transplantation, intensive care
MNA-SFa,21
Mild 1–3 kg in
last months
21–23 NS NS NS
Moderate “Does not know” 19–21 “Does not
go out”
Moderate loss of appetite
past 3 mo
Mild dementia
Severe >3 kg last
months
<19 Bed or chair
bound
Severe loss of appetite
past 3 mo
Acute disease past 3 mo,
or severe dementia/depression
MUST22
Medium risk 5–10% in
3–6 mo
18.5–20 NA NS NA
High risk >10% in
3–6 mo
<18.5 NA Acute illness AND no
food intake for >5 d
NA
aAdapted for older adults (>65 y)
NRS-2002 = Nutritional Risk Screening-2002, MNA-SF = Mini Nutritional Assessment-Short Form, MUST = Malnutrition Universal Screen-
ing Tool, NA = not applicable, NS = not specified
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